220 related articles for article (PubMed ID: 28710117)
1. Genetic and epigenetic drivers of neuroendocrine tumours (NET).
Di Domenico A; Wiedmer T; Marinoni I; Perren A
Endocr Relat Cancer; 2017 Sep; 24(9):R315-R334. PubMed ID: 28710117
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine tumours: cracking the epigenetic code.
Karpathakis A; Dibra H; Thirlwell C
Endocr Relat Cancer; 2013 Jun; 20(3):R65-82. PubMed ID: 23429748
[TBL] [Abstract][Full Text] [Related]
3. The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours.
Pipinikas CP; Berner AM; Sposito T; Thirlwell C
Endocr Relat Cancer; 2019 Aug; 26(9):R519-R544. PubMed ID: 31252410
[TBL] [Abstract][Full Text] [Related]
4. Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.
Boora GK; Kanwar R; Kulkarni AA; Pleticha J; Ames M; Schroth G; Beutler AS; Banck MS
Cancer Genet; 2015; 208(7-8):374-81. PubMed ID: 26087898
[TBL] [Abstract][Full Text] [Related]
5. NETs: organ-related epigenetic derangements and potential clinical applications.
Cives M; Simone V; Rizzo FM; Silvestris F
Oncotarget; 2016 Aug; 7(35):57414-57429. PubMed ID: 27418145
[TBL] [Abstract][Full Text] [Related]
6. Dictating genomic destiny: Epigenetic regulation of pancreatic neuroendocrine tumours.
Gundara JS; Jamal K; Kurzawinski T
Mol Cell Endocrinol; 2018 Jul; 469():85-91. PubMed ID: 28385665
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system.
Hong X; Qiao S; Li F; Wang W; Jiang R; Wu H; Chen H; Liu L; Peng J; Wang J; Jia C; Liang X; Dai H; Jiang J; Zhang T; Liao Q; Dai M; Cong L; Han X; Guo D; Liang Z; Li D; Zheng Z; Ye C; Li S; Zhao Y; Wu K; Wu W
Gut; 2020 May; 69(5):877-887. PubMed ID: 31462556
[TBL] [Abstract][Full Text] [Related]
9. Genetics and epigenetics in small intestinal neuroendocrine tumours.
Stålberg P; Westin G; Thirlwell C
J Intern Med; 2016 Dec; 280(6):584-594. PubMed ID: 27306880
[TBL] [Abstract][Full Text] [Related]
10. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium.
Mafficini A; Scarpa A
J Endocrinol; 2018 Mar; 236(3):R161-R167. PubMed ID: 29321190
[TBL] [Abstract][Full Text] [Related]
12. Hypo-methylation mediates chromosomal instability in pancreatic NET.
Marinoni I; Wiederkeher A; Wiedmer T; Pantasis S; Di Domenico A; Frank R; Vassella E; Schmitt A; Perren A
Endocr Relat Cancer; 2017 Mar; 24(3):137-146. PubMed ID: 28115389
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.
Larsson C
Neuroendocrinology; 2013; 97(1):19-25. PubMed ID: 22456267
[TBL] [Abstract][Full Text] [Related]
14. New Genetics and Genomic Data on Pancreatic Neuroendocrine Tumors: Implications for Diagnosis, Treatment, and Targeted Therapies.
Schmitt AM; Marinoni I; Blank A; Perren A
Endocr Pathol; 2016 Sep; 27(3):200-4. PubMed ID: 27456058
[TBL] [Abstract][Full Text] [Related]
15. Gastroenteropancreatic endocrine tumors.
Meeker A; Heaphy C
Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study.
Vijayvergia N; Boland PM; Handorf E; Gustafson KS; Gong Y; Cooper HS; Sheriff F; Astsaturov I; Cohen SJ; Engstrom PF
Br J Cancer; 2016 Aug; 115(5):564-70. PubMed ID: 27482646
[TBL] [Abstract][Full Text] [Related]
17. The epigenetic and transcriptional landscape of neuroendocrine prostate cancer.
Davies A; Zoubeidi A; Selth LA
Endocr Relat Cancer; 2020 Feb; 27(2):R35-R50. PubMed ID: 31804971
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
[TBL] [Abstract][Full Text] [Related]
19. Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead.
Colao A; de Nigris F; Modica R; Napoli C
Front Endocrinol (Lausanne); 2020; 11():604341. PubMed ID: 33384663
[TBL] [Abstract][Full Text] [Related]
20. Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids.
Dreijerink KM; Derks JL; Cataldo I; Scarpa A; Valk GD; Speel EJ
Front Horm Res; 2015; 44():115-38. PubMed ID: 26303708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]